[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rxsight Inc (RXST)

Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 297,115
  • Shares Outstanding, K 41,266
  • Annual Sales, $ 134,480 K
  • Annual Income, $ -38,940 K
  • EBIT $ -48 M
  • EBITDA $ -53 M
  • 60-Month Beta 1.22
  • Price/Sales 2.27
  • Price/Cash Flow N/A
  • Price/Book 1.10

Options Overview Details

View History
  • Implied Volatility 257.48% (-6.79%)
  • Historical Volatility 61.67%
  • IV Percentile 74%
  • IV Rank 33.49%
  • IV High 673.85% on 03/30/26
  • IV Low 47.83% on 05/21/25
  • Expected Move (DTE 21) 0.85 (11.72%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 200
  • Volume Avg (30-Day) 65
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 1,195
  • Open Int (30-Day) 1,635
  • Expected Range 6.40 to 8.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.30
  • Number of Estimates 2
  • High Estimate $-0.30
  • Low Estimate $-0.30
  • Prior Year $-0.20
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.90 +22.88%
on 03/31/26
7.72 -6.09%
on 04/17/26
+0.99 (+15.81%)
since 03/24/26
3-Month
5.90 +22.88%
on 03/31/26
9.85 -26.40%
on 01/26/26
-2.26 (-23.76%)
since 01/23/26
52-Week
5.90 +22.88%
on 03/31/26
16.74 -56.69%
on 05/20/25
-7.48 (-50.76%)
since 04/24/25

Most Recent Stories

More News
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday,...

RXST : 7.25 (+0.69%)
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over...

RXST : 7.25 (+0.69%)
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)  RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management...

RXST : 7.25 (+0.69%)
RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance

ALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and...

RXST : 7.25 (+0.69%)
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

RXST : 7.25 (+0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK , Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST).  Such investors are advised...

RXST : 7.25 (+0.69%)
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 7.25 (+0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK , Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST).  Such investors are advised to...

RXST : 7.25 (+0.69%)
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

RXST : 7.25 (+0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK , Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST).  Such investors are advised to...

RXST : 7.25 (+0.69%)

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 7.54
2nd Resistance Point 7.41
1st Resistance Point 7.33
Last Price 7.25
1st Support Level 7.12
2nd Support Level 6.99
3rd Support Level 6.91

See More

52-Week High 16.74
Fibonacci 61.8% 12.60
Fibonacci 50% 11.32
Fibonacci 38.2% 10.04
Last Price 7.25
52-Week Low 5.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.